To directly determine the impact of the absence of EphA3 on T-ALL occurrence in this model, we compared the T-ALL-free survival of NHD13-EphA3+/+ and NHD13-EphA3−/− mice (Figure 3A). This evidence concerns the gene EPHA3 and acute lymphoblastic leukemia.